Oncode has developed an overarching valorization strategy solely focused on oncology, which is designed to accelerate the translation of new insights in cancer biology into tangible applications for patients and society. A devoted team of international experts and dedicated valorization funds are the driving forces behind Oncode’s valorization strategy. Oncode’s business developers are the first point of contact for OIs and have become an integrated part of the research groups. This has the benefit that potential breakthrough discoveries are recognized at an early stage and coupled to suitable valorization funds and tools. In 2020, the valorization team got up to full speed and is already surpassing the yearly targets set at the onset of Oncode.


success rate strategic funding support


Clinical Proof of Concept studies towards Affordable Health Care


new invention disclosures in 2020


license agreements in 2020


Outsmarting cancer

impacting lives

Valorization in person

Outsmarting cancer

impacting lives